Work

P-214 A phase 2 trial of leflunomide, pomalidomide, and dexamethasone for relapsed/refractory multiple myeloma

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01832-3

Authors: Michael Rosenzweig, James Sanchez, Arnab Chowdhury, Nitya Nathwani, Murali Janakiram, Myo Htut, Firoozeh Sahebi, Tricia Walker, Flavia Pichiorri, Joycelynne Palmer, Amrita Krishnan, Jonathan Keats, Steven Rosen

Institutions: City Of Hope National Medical Center, City of Hope, Translational Genomics Research Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387003826

Cites:

Cited by:

Related to: 10